Exelixis director granted options on 19,133 shares

EXELIXIS, INC. director David Edward Johnson reported receiving an option grant covering 19,133 shares of common stock.

Rhea-AI Filing Summary

EXELIXIS, INC. director David Edward Johnson reported receiving an option grant covering 19,133 shares of common stock. The option has an exercise price of $50.03 per share, is exercisable immediately subject to repurchase provisions, and expires on May 26, 2033. It will vest in full on the first anniversary of the grant date, conditioned on Mr. Johnson’s continuous service. After this award, he holds options for 19,133 shares. Footnotes state the securities are deemed held for the benefit of Caligan Partners Master Fund LP and certain managed accounts of Caligan Partners LP, and may be transferred to those entities after vesting.

Insider Trade Summary

Grant/Award: 19,133 shares

Grant/Award 1 txn

Insider JOHNSON DAVID EDWARD, Caligan Partners LP

Role Director | Director

Type	Security	Shares	Price	Value
Grant/Award	Option (right to buy)	19,133	$0.00	$0.00

Holdings After Transaction: Option (right to buy) — 19,133 contracts (Direct)

Footnotes (2)

1. F1. Option granted to David Johnson ("Mr. Johnson") pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The option is exercisable immediately, subject to repurchase provisions, and will vest as to 100% of the shares subject to the option on the first anniversary of the date of grant, subject to Mr. Johnson's continuous service through such date.
2. F2. Mr. Johnson is deemed to hold the securities reported herein for the benefit of Caligan Partners Master Fund LP (the "Caligan Master Fund") and managed accounts to which Caligan Partners LP ("Caligan") serves as investment manager (the "Caligan Accounts", together with the Caligan Master Fund, the "Caligan Master Fund and Accounts"), and may, after vesting, if applicable, transfer the securities directly to the Caligan Master Fund and Accounts.

Key Figures

Option shares granted: 19,133 shares Exercise price: $50.03 per share Expiration date: May 26, 2033 +2 more

5 metrics

Option shares granted 19,133 shares Option (right to buy) granted on May 27, 2026

Exercise price $50.03 per share Strike price of option grant

Expiration date May 26, 2033 Option expiration

Underlying common shares 19,133 shares Common stock underlying the option

Total options after grant 19,133 shares Options beneficially owned following transaction

Key Terms

Equity Incentive Plan, repurchase provisions, vest, benefit of Caligan Partners Master Fund LP, +1 more

5 terms

Equity Incentive Plan financial

"Option granted to David Johnson pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan."

An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.

repurchase provisions financial

"The option is exercisable immediately, subject to repurchase provisions, and will vest as to 100% of the shares"

vest financial

"and will vest as to 100% of the shares subject to the option on the first anniversary of the date of grant"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

benefit of Caligan Partners Master Fund LP financial

"Mr. Johnson is deemed to hold the securities reported herein for the benefit of Caligan Partners Master Fund LP"

managed accounts financial

"and managed accounts to which Caligan Partners LP serves as investment manager"

Managed accounts are collections of investments owned by an individual or institution but run day-to-day by a professional who buys, sells and allocates assets according to an agreed plan. They matter to investors because they provide tailored oversight, active risk control and potential tax efficiency—like hiring a personal chef to manage your diet—while fees and the manager’s skill directly affect returns.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did the EXEL director report on this Form 4 for EXELIXIS, INC. (EXEL)?

The Form 4 reports a grant of stock options to director David Edward Johnson for 19,133 shares at an exercise price of $50.03 per share. These options are part of Exelixis’ 2017 Equity Incentive Plan and represent compensation rather than an open-market share purchase or sale.

What are the key terms of David Johnson’s stock option grant at EXELIXIS, INC. (EXEL)?

David Johnson received options over 19,133 shares of common stock with a $50.03 exercise price, exercisable immediately subject to repurchase provisions. The award vests 100% on the first anniversary of the grant date, provided he remains in continuous service through that vesting date.

When do the new EXEL stock options granted to David Johnson vest and expire?

The options will vest as to 100% of the 19,133 underlying shares on the first anniversary of the grant date, assuming continuous service. They are immediately exercisable subject to repurchase provisions and will expire on May 26, 2033, giving a multi‑year window for potential exercise.

How many EXELIXIS, INC. (EXEL) option shares does David Johnson hold after this transaction?

Following this grant, David Johnson holds options covering 19,133 shares of Exelixis common stock. This figure reflects the total options reported as beneficially owned after the transaction in the Form 4 and does not include any other potential holdings not shown here.

How are Caligan Partners and related funds involved in this EXEL Form 4 filing?

Footnotes state David Johnson is deemed to hold the reported securities for the benefit of Caligan Partners Master Fund LP and certain managed accounts of Caligan Partners LP. After vesting, the options or underlying shares may be transferred directly to these Caligan-related funds and accounts.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/29/2026 - 04:30 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

JOHNSON DAVID EDWARD

(Last) (First) (Middle)

780 THIRD AVENUE

30TH FLOOR

(Street)

NEW YORK NEW YORK 10017

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
EXELIXIS, INC. [ EXEL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option (right to buy)	$50.03	05/27/2026		A		19,133		05/27/2026(1)	05/26/2033	Common Stock	19,133	$0	19,133	D(2)

1. Name and Address of Reporting Person^*

JOHNSON DAVID EDWARD

(Last) (First) (Middle)

780 THIRD AVENUE

30TH FLOOR

(Street)

NEW YORK NEW YORK 10017

(City) (State) (Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Caligan Partners LP

(Last) (First) (Middle)

780 THIRD AVENUE

30TH FLOOR

(Street)

NEW YORK NEW YORK 10017

(City) (State) (Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer

X	Director		10% Owner
	Officer (give title below)	X	Other (specify below)
			See Remarks

Explanation of Responses:

1. Option granted to David Johnson ("Mr. Johnson") pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The option is exercisable immediately, subject to repurchase provisions, and will vest as to 100% of the shares subject to the option on the first anniversary of the date of grant, subject to Mr. Johnson's continuous service through such date.

2. Mr. Johnson is deemed to hold the securities reported herein for the benefit of Caligan Partners Master Fund LP (the "Caligan Master Fund") and managed accounts to which Caligan Partners LP ("Caligan") serves as investment manager (the "Caligan Accounts", together with the Caligan Master Fund, the "Caligan Master Fund and Accounts"), and may, after vesting, if applicable, transfer the securities directly to the Caligan Master Fund and Accounts.

Remarks:

Each Reporting Person disclaims beneficial ownership in the securities reported on this Form 4 except to the extent of its or his pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Caligan may be deemed to be a director by deputization of the Issuer by virtue of the fact that Mr. Johnson currently serves on the Issuer's board of directors.

	/s/ David Edward Johnson	05/29/2026
	Caligan Partners LP, By: /s/ David Johnson, Managing Partner	05/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)